FDA. Information about Naloxone Naloxone is a medication that rapidly reverses the effects of opioid overdose and is the standard treatment for overdose. In the wake of the opioid epidemic, efforts are underway to make this emergency treatment more…

USA. FDA Approves Amphastar Pharma's Nasal Spray for Opioid Overdose Amphastar Pharmaceuticals Inc said on Wednesday the U.S. Food and Drug Administration (FDA) had approved its nasal spray for emergency treatment of known or suspected opioid overd…

Harm reduction behaviors are associated with carrying naloxone among patients on methadone treatment.  Kozak Z, Ciccarone D, Thrul J, Cole TO, Pappas AL, Greenblatt AD, Welsh C, Yoon M, Gann D Jr, Artigiani EE, Wish ED, Belcher AM.  Harm…

Naloxone expansion is not associated with increases in adolescent heroin use and injection drug use: Evidence from 44 US states.  Bruzelius E, Cerdá M, Davis CS, Jent V, Wheeler-Martin K, Mauro CM, Crystal S, Keyes KM, Samples H, Hasin DS, Mar…

How do contextual factors influence naloxone distribution from syringe service programs in the USA: a cross-sectional study.  Lambdin BH, Wenger L, Bluthenthal R, Bartholomew TS, Tookes HE, LaKosky P, O'Neill S, Kral AH.  Harm Reduct J…

Racial/ethnic disparities in opioid overdose prevention: comparison of the naloxone care cascade in White, Latinx, and Black people who use opioids in New York City.  Khan MR, Hoff L, Elliott L, Scheidell JD, Pamplin JR 2nd, Townsend TN, Irvin…